Literature DB >> 25239782

Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study.

Rachel Bedenis1, Anna H Price2, Christine M Robertson2, Jo R Morling2, Brian M Frier3, Mark W J Strachan4, Jackie F Price2.   

Abstract

OBJECTIVE: To determine whether a history of severe hypoglycemia was associated with an increased risk of subsequent macrovascular events in people with type 2 diabetes and to explore possible mediation of this association by inflammation. RESEARCH DESIGN AND METHODS: A cohort of 1,066 adults aged 60-75 years with type 2 diabetes was evaluated prospectively. Baseline history of severe hypoglycemia and plasma levels of the inflammatory markers C-reactive protein, fibrinogen, interleukin-6, and tumor necrosis factor-α were recorded. Their association with incident macrovascular events after 4 years was explored.
RESULTS: At baseline, 87 participants (8.2%) reported one or more episodes of severe hypoglycemia within the preceding year, and at follow-up 99 participants (9.3%) had suffered a new macrovascular event. Hypoglycemia was associated with increased odds of macrovascular events (odds ratio [OR] 2.11 [95% CI 1.06, 4.21], P = 0.035), including coronary heart events (OR 2.44 [95% CI 1.13, 5.26], P = 0.023), largely due to increased myocardial infarction (OR 4.02 [95% CI 1.54, 10.48], P = 0.004). Hypoglycemia was also associated with increased levels of inflammatory markers, including a general inflammation factor derived using principal-components analysis (P = 0.030, after adjustment for cardiometabolic risk factors). However, the significant association between hypoglycemia and macrovascular events persisted after adjustment for inflammatory markers.
CONCLUSIONS: The odds of suffering a macrovascular event were higher in patients with type 2 diabetes who had a history of severe hypoglycemia. There was no evidence that a proinflammatory state had a major role in mediating this association.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25239782     DOI: 10.2337/dc14-0908

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  31 in total

1.  Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles.

Authors:  Michael J Tanner; Jingli Wang; Rong Ying; Tisha B Suboc; Mobin Malik; Allison Couillard; Amberly Branum; Venkata Puppala; Michael E Widlansky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

2.  Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes.

Authors:  Nino G Joy; Maia Mikeladze; Lisa M Younk; Donna B Tate; Stephen N Davis
Journal:  Metabolism       Date:  2016-09-12       Impact factor: 8.694

3.  Severe Hypoglycemia and Incident Heart Failure Among Adults With Type 2 Diabetes.

Authors:  Justin B Echouffo-Tcheugui; Arnaud D Kaze; Gregg C Fonarow; Sam Dagogo-Jack
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

4.  Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans.

Authors:  Nino G Joy; Jennifer M Perkins; Maia Mikeladze; Lisa Younk; Donna B Tate; Stephen N Davis
Journal:  J Diabetes Complications       Date:  2016-07-04       Impact factor: 2.852

Review 5.  The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?

Authors:  Laurentiu M Pop; Ildiko Lingvay
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

Review 6.  Felix dies natalis, insulin… ceterum autem censeo "beta is better".

Authors:  Lorenzo Piemonti
Journal:  Acta Diabetol       Date:  2021-05-23       Impact factor: 4.280

7.  Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial.

Authors:  Fukumi Yoshikawa; Tomoko Nagashima; Hiroshi Uchino; Shuki Usui; Masahiko Miyagi; Yasuyo Ando; Takahisa Hirose
Journal:  Diabetol Int       Date:  2021-06-05

Review 8.  Association Between Severe Hypoglycemia and Cardiovascular Disease Risk in Japanese Patients With Type 2 Diabetes.

Authors:  Atsushi Goto; Maki Goto; Yasuo Terauchi; Naohito Yamaguchi; Mitsuhiko Noda
Journal:  J Am Heart Assoc       Date:  2016-03-09       Impact factor: 5.501

9.  Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes.

Authors:  Seon Ah Cha; Jae Seung Yun; Tae Seok Lim; Seawon Hwang; Eun Jung Yim; Ki Ho Song; Ki Dong Yoo; Yong Moon Park; Yu Bae Ahn; Seung Hyun Ko
Journal:  Diabetes Metab J       Date:  2016-04-21       Impact factor: 5.376

10.  Understanding the impact of hypoglycemia on the cardiovascular system.

Authors:  Ian Charles Davis; Ida Ahmadizadeh; Jacqueline Randell; Lisa Younk; Stephen N Davis
Journal:  Expert Rev Endocrinol Metab       Date:  2017-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.